Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Fierce Biotech
Thu, 02/4/21 - 10:36 am
Tags:
Roche, earnings, cancer, autoimmune disease, drug development
Roche and Genentech's latest AI collaborator raises $25M Series A to reinvent one of the oldest cancer targets
Endpoints
Wed, 02/3/21 - 10:50 am
Tags:
Roche, Genentech, artificial intelligence, machine learning, kinases, Reverie Labs
Roche eyes FDA filing after bispecific matches Eylea again
Fierce Biotech
Mon, 01/25/21 - 10:44 am
Tags:
Roche, bispecifics, Regeneron, Eylea, clinical trials, faricimab, wet age-related macular degeneration
Further Studies Show Conflicting Results of Arthritis Drug for Severe COVID-19
BioSpace
Fri, 01/22/21 - 10:35 am
Tags:
COVID-19, arthritis, Actemra, RoActemra, Roche
With patent concerns looming, Roche gets a new priority review on blockbuster IPF drug
Endpoints
Thu, 01/21/21 - 10:36 am
Tags:
Roche, Esbriet, IPF, FDA, priority review
AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
Tags:
AstraZeneca, Daiichi Sankyo, stomach cancer, Enhertu, Roche, Herceptin
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
Tags:
clinical trials, Novavax, AstraZeneca, JNJ, vaccines, COVID-19, Biomarin, Amgen, Merck, Pfizer, Roche, SAGE Therapeutics, Biogen, Vertex Pharmaceuticals
Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
Reuters
Thu, 01/7/21 - 11:18 pm
Tags:
COVID-19, Roche, Actemra, Sanofi, Kevzara
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genetic Engineering News
Wed, 01/6/21 - 11:27 pm
Tags:
Genentech, Roche, Ribometrix, small molecule drugs, drug discovery, R&D
Roche gets FDA breakthrough therapy status for tiragolumab plus Tecentriq
Pharmaceutical Business Review
Wed, 01/6/21 - 10:37 am
Tags:
Roche, FDA, tiragolumab, Tecentriq, non-small cell lung cancer, breakthrough therapies
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Wed, 12/30/20 - 10:53 am
Tags:
Merck, Bristol-Myers Squibb, AstraZeneca, Roche, Keytruda, Opdivo, Imfinzi, Tecentriq, China, PD-1 inhibitors
Roche eyes an uncertain market for faricimab
EP Vantage
Tue, 12/22/20 - 10:49 am
Tags:
Roche, faricimab, diabetic macular edema, Regeneron, Eylea
Roche's bispecific matches Regeneron's Eylea in phase 3 trials
Fierce Biotech
Mon, 12/21/20 - 11:02 am
Tags:
Roche, faricimab, diabetic macular edema, clinical trials, Regeneron, Eylea, bispecific antibodies
MacroGenics wins FDA approval of breast cancer drug
BioPharma Dive
Thu, 12/17/20 - 06:15 pm
Tags:
Margenza, Macrogenics, FDA, breast cancer, Roche, Herceptin
Roche's MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
Fierce Pharma
Tue, 12/15/20 - 08:29 pm
Tags:
Roche, Novartis, Kesimpta, Ocrevus, MS, multiple sclerosis
Genentech pays Relay $75M for cancer drug, plans KRAS combo
Fierce Biotech
Mon, 12/14/20 - 11:07 am
Tags:
Genentech, Relay Therapeutics, Roche, KRAS inhibitors
Roche yields to cancer biosim competition by offering 'relevant' discounts: report
Fierce Pharma
Thu, 12/10/20 - 07:19 pm
Tags:
Roche, biosimilars, CMS, discounts, buy-and-bill
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Wed, 12/2/20 - 10:33 am
Tags:
Roche, Blueprint Medicines, Gavreto, thyroid cancer, Retevmo, Eli Lilly
Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche
Pharmaforum
Wed, 12/2/20 - 10:29 am
Tags:
Noema, neurological disorders, Roche
Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup
Endpoints
Tue, 12/1/20 - 10:46 am
Tags:
startups, Neuroscience, psychiatry, Roche, Noema

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.